World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
14274
World Ranking
3137
National Ranking
120

Josée Golay publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Josée Golay sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 160 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Josée Golay D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Josée Golay sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Josée Golay is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research spans several interconnected fields, primarily focusing on medicine, biochemistry, genetics, and molecular biology. The researcher has contributed extensively to oncology, genetics, immunology, molecular biology, and radiology through a variety of scientific studies.

The main areas of research conducted by Josée Golay include:

  • CAR-T cell therapy research
  • Monoclonal and Polyclonal Antibodies Research
  • Virus-based gene therapy research
  • Chronic Lymphocytic Leukemia Research
  • Immune Cell Function and Interaction
  • Mesenchymal stem cell research
  • Glycosylation and Glycoproteins Research

Notable recent publications by Josée Golay feature several key topics related to antibodies and cell therapy. These include:

  • The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs, 2020, Antibodies
  • Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies, 2022, Frontiers in Immunology

Josée Golay regularly publishes in high-impact venues, with frequent contributions to:

  • Antibodies
  • Frontiers in Immunology
  • Cytotherapy
  • Blood
  • Blood Cancer Journal

The researcher often collaborates with a set of frequent coauthors, including:

  • Martino Introna
  • Alessandro Rambaldi
  • Chiara Capelli
  • Irene Cattaneo
  • Elisa Gotti

Josée Golay's research contributions focus notably on advancing understanding and therapeutic applications in immunology and oncology. Their work on CAR-T cells, monoclonal antibodies, and glycosylation processes addresses key mechanisms relevant to cancer treatment and immune modulation.

Best Publications

  • Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis

    Josée Golay;Luisella Zaffaroni;Thomas Vaccari;Thomas Vaccari;Manuela Lazzari;Manuela Lazzari

  • Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo

    Nicola Di Gaetano;Elena Cittera;Rachele Nota;Annunciata Vecchi

  • From the bench to the bedside: ways to improve rituximab efficacy

    Guillaume Cartron;Hervé Watier;Josée Golay;Philippe Solal-Celigny

  • Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component.

    F Breviario;E M d'Aniello;J Golay;G Peri

  • CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

    Josée Golay;Manuela Lazzari;Valeria Facchinetti;Sergio Bernasconi

  • The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells.

    Emer Bourke;Daniela Bosisio;Josée Golay;Nadia Polentarutti

  • Dual-functional capability of CD3 +CD56 + CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity

    Alice Pievani;Gianmaria Borleri;Daniela Pende;Lorenzo Moretta

  • Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes

    Victor Vidai Alles;Barbara Bottazzi;Giuseppe Peri;Josée Golay

  • Autologous Mesenchymal Stromal Cells and Kidney Transplantation: A Pilot Study of Safety and Clinical Feasibility

    Norberto Perico;Federica Casiraghi;Martino Introna;Eliana Gotti

  • M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro

    Marzia Leidi;Elisa Gotti;Luca Bologna;Elena Miranda

  • Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab.

    Josée Golay;Fabio Da Roit;Luca Bologna;Claudia Ferrara

  • Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone

    N. Di Gaetano;Y. Xiao;E. Erba;R. Bassan

  • Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study

    Martino Introna;Gianmaria Borleri;Elena Conti;Marta Franceschetti

  • Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients.

    Martino Introna;Giovanna Lucchini;Erica Dander;Stefania Galimberti

  • Mechanism of Action of Type II, Glycoengineered, Anti-CD20 Monoclonal Antibody GA101 in B-Chronic Lymphocytic Leukemia Whole Blood Assays in Comparison with Rituximab and Alemtuzumab

    Luca Bologna;Elisa Gotti;Massimiliano Manganini;Alessandro Rambaldi

  • The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle.

    J. T. Golay;E. A. Clark;P. C. L. Beverley

  • Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population.

    Giovanna Lucchini;Martino Introna;Erica Dander;Attilio Rovelli

  • Genetic modification of human T cells with CD20 : A strategy to purify and lyse transduced cells with anti-CD20 antibodies

    Martino Introna;Anna M. Barbui;Federica Bambacioni;Chiara Casati

  • Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts.

    C Capelli;M Domenghini;G Borleri;P Bellavita

  • Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes

    Marta Franceschetti;Alice Pievani;Gianmaria Borleri;Luca Vago

Frequent Co-Authors

Martino Introna
Martino Introna Mario Negri Institute for Pharmacological Research
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Andrea Biondi
Andrea Biondi University of Milano-Bicocca
Tiziano Barbui
Tiziano Barbui FROM-Fondazione per la Ricerca Ospedale di Bergamo
Sergio Bernasconi
Sergio Bernasconi University of Parma
Alberto Mantovani
Alberto Mantovani Humanitas University
Giovanni Cazzaniga
Giovanni Cazzaniga University of Milano-Bicocca
Giuseppe Peri
Giuseppe Peri Mario Negri Institute for Pharmacological Research
Guido Finazzi
Guido Finazzi Mario Negri Institute for Pharmacological Research
Antonino Neri
Antonino Neri University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens diverse career paths in healthcare and research. For those interested in clinical applications, exploring online accelerated nursing programs for non nurses can provide an efficient route into nursing, even without a prior healthcare background.

If you’re aiming to quickly enter the nursing profession, consider options like accelerated nursing programs. These programs are designed to build your clinical knowledge fast and prepare you for roles in hospitals or research settings.

For those interested in foundational nursing roles, exploring easy lpn programs to get into can be a practical starting point. Licensed Practical Nurse qualifications help build valuable patient care skills that complement immunological studies.

Advancing further, becoming a Nurse Practitioner is another promising pathway. Many students benefit from choosing easy nurse practitioner programs to get into that balance accessibility with strong clinical training, leading to impactful roles in primary care and disease management.

Best Scientists Citing Josée Golay

Trending Scientists

Recently Published Articles